Natera Operating Income 2014-2024 | NTRA
Natera annual/quarterly operating income history and growth rate from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Natera operating income for the quarter ending December 31, 2024 was $-0.065B, a 23.42% decline year-over-year.
- Natera operating income for the twelve months ending December 31, 2024 was $-0.222B, a 50.19% decline year-over-year.
- Natera annual operating income for 2024 was $-0.222B, a 50.19% decline from 2023.
- Natera annual operating income for 2023 was $-0.446B, a 17.52% decline from 2022.
- Natera annual operating income for 2022 was $-0.541B, a 15.56% increase from 2021.
| Natera Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-222 |
| 2023 | $-446 |
| 2022 | $-541 |
| 2021 | $-468 |
| 2020 | $-216 |
| 2019 | $-116 |
| 2018 | $-115 |
| 2017 | $-135 |
| 2016 | $-101 |
| 2015 | $-60 |
| 2014 | $1 |
| 2013 | $-25 |
| Natera Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-65 |
| 2024-09-30 | $-39 |
| 2024-06-30 | $-44 |
| 2024-03-31 | $-74 |
| 2023-12-31 | $-85 |
| 2023-09-30 | $-111 |
| 2023-06-30 | $-112 |
| 2023-03-31 | $-138 |
| 2022-12-31 | $-142 |
| 2022-09-30 | $-119 |
| 2022-06-30 | $-143 |
| 2022-03-31 | $-137 |
| 2021-12-31 | $-140 |
| 2021-09-30 | $-150 |
| 2021-06-30 | $-115 |
| 2021-03-31 | $-63 |
| 2020-12-31 | $-74 |
| 2020-09-30 | $-56 |
| 2020-06-30 | $-52 |
| 2020-03-31 | $-35 |
| 2019-12-31 | $-35 |
| 2019-09-30 | $-21 |
| 2019-06-30 | $-29 |
| 2019-03-31 | $-32 |
| 2018-12-31 | $-30 |
| 2018-09-30 | $-27 |
| 2018-06-30 | $-27 |
| 2018-03-31 | $-31 |
| 2017-12-31 | $-47 |
| 2017-09-30 | $-26 |
| 2017-06-30 | $-28 |
| 2017-03-31 | $-35 |
| 2016-12-31 | $-42 |
| 2016-09-30 | $-27 |
| 2016-06-30 | $-23 |
| 2016-03-31 | $-10 |
| 2015-12-31 | $-17 |
| 2015-09-30 | $-21 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-6 |
| 2014-12-31 | |
| 2014-09-30 | $5 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.018B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| Revvity (RVTY) | United States | $11.032B | 18.74 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Doximity (DOCS) | United States | $9.934B | 51.66 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| HealthEquity (HQY) | United States | $7.311B | 35.97 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |